skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Thoracic Oncology remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
Material Type:
Artigo 		Adicionar ao Meu Espaço

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Cui, W. ; Milner-Watts, C. ; Saith, S. ; Bhosle, J. ; Minchom, A.R. ; Davidson, M. ; Page, S. ; Locke, I. ; Yousaf, N. ; Popat, S. ; O'Brien, M.E.R.

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S795-S795 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
Material Type:
Artigo 		Adicionar ao Meu Espaço

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Pierre, C. ; Goter, T. ; Agar, C. ; Luzi, S. ; Lena, H. ; Guen, Y. Le ; Ricordel, C.

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S794-S795 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study

Marin, E. ; Teixido, C. ; Arcocha, A. ; Castillo, S. ; Reyes, R. ; Viñolas, N. ; Mezquita, L. ; Muñoz, S. ; Martinez, D. ; Jares, P. ; Reguart, N.

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S796-S797 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Le, Xiuning ; Nilsson, Monique ; Goldman, Jonathan ; Reck, Martin ; Nakagawa, Kazuhiko ; Kato, Terafumi ; Ares, Luis Paz ; Frimodt-Moller, Bente ; Wolff, Katharina ; Visseren-Grul, Carla ; Heymach, John V. ; Garon, Edward B.

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.205-215 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

Jin, Yueping ; Dong, Hui ; Xia, Liliang ; Yang, Yi ; Zhu, Yongqiang ; Shen, Yan ; Zheng, Huajun ; Yao, Chengcheng ; Wang, Ying ; Lu, Shun

Journal of thoracic oncology, 2019-08, Vol.14 (8), p.1378-1389 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Zhou, Caicun ; Wu, Lin ; Fan, Yun ; Wang, Zhehai ; Liu, Lianke ; Chen, Gongyan ; Zhang, Li ; Huang, Dingzhi ; Cang, Shundong ; Yang, Zhixiong ; Zhou, Jianying ; Zhou, Chengzhi ; Li, Baolan ; Li, Juan ; Fan, Min ; Cui, Jiuwei ; Li, Yuping ; Zhao, Hui ; Fang, Jian ; Xue, Jianxin ; Hu, Chengping ; Sun, Ping ; Du, Yingying ; Zhou, Hui ; Wang, Shuyan ; Zhang, Wen

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Wu, Yi-Long ; Lu, Shun ; Cheng, Ying ; Zhou, Caicun ; Wang, Jie ; Mok, Tony ; Zhang, Li ; Tu, Hai-Yan ; Wu, Lin ; Feng, Jifeng ; Zhang, Yiping ; Luft, Alexander Valerievich ; Zhou, Jianying ; Ma, Zhiyong ; Lu, You ; Hu, Chengping ; Shi, Yuankai ; Baudelet, Christine ; Cai, Junliang ; Chang, Jianhua

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.867-875 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab
Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab

Scott, Susan C. ; Pennell, Nathan A.

Journal of thoracic oncology, 2018-11, Vol.13 (11), p.1771-1775 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Rolfo, Christian ; Mack, Philip C. ; Scagliotti, Giorgio V. ; Baas, Paul ; Barlesi, Fabrice ; Bivona, Trever G. ; Herbst, Roy S. ; Mok, Tony S. ; Peled, Nir ; Pirker, Robert ; Raez, Luis E. ; Reck, Martin ; Riess, Jonathan W. ; Sequist, Lecia V. ; Shepherd, Frances A. ; Sholl, Lynette M. ; Tan, Daniel S.W. ; Wakelee, Heather A. ; Wistuba, Ignacio I. ; Wynes, Murry W. ; Carbone, David P. ; Hirsch, Fred R. ; Gandara, David R.

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1248-1268 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC

Spigel, David R. ; Chaft, Jamie E. ; Gettinger, Scott ; Chao, Bo H. ; Dirix, Luc ; Schmid, Peter ; Chow, Laura Q.M. ; Hicks, Rodney J. ; Leon, Larry ; Fredrickson, Jill ; Kowanetz, Marcin ; Sandler, Alan ; Funke, Roel ; Rizvi, Naiyer A.

Journal of thoracic oncology, 2018-11, Vol.13 (11), p.1733-1742 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.